| Date Filed | Type | Description |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
4
| MOSCICKI RICHARD A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 10,869 options to buy
@ $12.65, valued at
$137.5k
|
|
| 06/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2018 |
4
| MOSCICKI RICHARD A (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 24,102 options to buy
@ $10, valued at
$241k
|
|
| 10/18/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/06/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/18/2010 |
4
| MOSCICKI RICHARD A (Sr VP,Chief Medical Officer) has filed a Form 4 on GENZYME CORP|
Txns:
| Granted 23,038 options to buy
@ $51.52, valued at
$1.2M
|
|
| 05/26/2010 |
4
| MOSCICKI RICHARD A (Sr VP,Chief Medical Officer) has filed a Form 4 on GENZYME CORP|
Txns:
| Sold 2,731 shares
@ $45.63, valued at
$124.6k
Exercised 8,083 restricted stock units
@ $0 |
|
| 05/18/2010 |
4
| MOSCICKI RICHARD A (Sr VP,Chief Medical Officer) has filed a Form 4 on GENZYME CORP|
Txns:
| Sold 18,318 shares
@ $50.7, valued at
$928.7k
Exercised 18,318 options to buy
@ $26.5, valued at
$485.4k
|
|
| 05/26/2009 |
4
| MOSCICKI RICHARD A (Sr VP,Chief Medical Officer) has filed a Form 4 on GENZYME CORP |
| 02/07/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |